![]() |
|
|
Vol. 280, Issue 3, 1184-1191, 1997
Pharmaceuticals Research Laboratories, We investigated the effects of cilnidipine, a dihydropyridine
derivative, on neuronal Ca++ channels in rat dorsal root
ganglion neurons. Voltage-dependent Ca++-channel currents
were recorded, using 5 mM Ba++ as the charge carrier, by
means of the whole-cell patch-clamp technique. The Ba++
current was subdivided pharmacologically into calciseptine-sensitive (L-type),
-conotoxin GVIA- (
CgTx) sensitive (N-type),
-agatoxin IVA- (
AgTx) sensitive (P/Q-type) and toxin-resistant
currents. Cilnidipine inhibited the L-type current with an
IC50 of 100 nM in neurons pretreated with
CgTx plus
AgTx. In neurons pretreated with Cal plus
AgTx, cilnidipine
induced a potent inhibition of the N-type current, but was unable to
block the residual Ba++ current. The IC50 for
cilnidipine in respect of the N-type current was 200 nM. Cilnidipine
(300-500 nM) modified neither the voltage-dependent inactivation curve
nor the decay of the N-type current. Furthermore, elevation of the
holding potential did not enhance the inhibitory action of cilnidipine
(300 nM) on the N-type current. No effect was induced by 100 nM
cilnidipine on the P/Q-type current. However, nicardipine (1 µM)
barely inhibited the N-type current at a concentration that almost
completely blocked the L-type current. In conclusion, cilnidipine has
potent inhibitory actions on N-type as well as L-type voltage-dependent
Ca++-channel in rat dorsal root ganglion neurons. The
former action may bestow an additional clinical advantage for the
treatment of hypertension, such as suppression of reflex tachycardia.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
M. Yamakage and A. Namiki Calcium channels - basic aspects of their structure, function and gene encoding; anesthetic action on the channels - a review: [Revue : notions de base sur la structure, la fonction et l'encodage genetique des canaux calciques et action des anesthesiques sur ces canaux] Can J Anesth, February 1, 2002; 49(2): 151 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamasaki, M. Ohmagari, I. Tamai, K. Hayashi, and Y. Matsumura Inhibitory Effects of AE0047, a New Dihydropyridine Ca2+ Channel Blocker, on Renal Nerve Stimulation-Induced Renal Actions in Anesthetized Dogs J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1040 - 1047. [Abstract] [Full Text] |
||||
![]() |
T. Furukawa, T. Yamakawa, T. Midera, T. Sagawa, Y. Mori, and T. Nukada Selectivities of Dihydropyridine Derivatives in Blocking Ca2+ Channel Subtypes Expressed in Xenopus Oocytes J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 464 - 473. [Abstract] [Full Text] |
||||
![]() |
H. Uneyama, H. Uchida, R. Yoshimoto, S. Ueno, K. Inoue, and N. Akaike Effects of a Novel Antihypertensive Drug, Cilnidipine, on Catecholamine Secretion From Differentiated PC12 Cells Hypertension, May 1, 1998; 31(5): 1195 - 1199. [Abstract] [Full Text] [PDF] |
||||